Summary
Overview
Work History
Education
Skills
Accomplishments
Work Preference
Work Availability
Languages
Interests
Timeline
Generic
Thu Van Trinh

Thu Van Trinh

Dr.
HCMC

Summary

Out-come based planning and patient (customer) centricity approach. Thorough team contributor with strong organizational capabilities and managing multiple priorities with a positive attitude. Combines strategic thinking with hands-on experience to deliver impactful solutions and enhance organizational performance and willingness to take on added responsibilities to meet team goals and work aspiration.


Overview

31
31
years of professional experience

Work History

Head of Medicine

Boehringer Ingelheim HP
07.2023 - Current
  • Steer the medical organization and provide governance fir all functions to Medicine in Vietnam (Medical Affairs, Regulatory Affairs, Stroke Care Unit and Pharmacovigilance)
  • Member of Executive Committee of Boehringer Vietnam and member of Human Pharma Business Leadership Team and share the responsibility to drive the Pharma business to achieve financial target contribute to the company ambition.
  • Provide on-going medical and regulatory expertise and input to local business.
  • Provide as an expert, strategic and pragmatic advice on medical and commercial matters including early launch plan, pre-launch strategy and execution planning.
  • Coach and lead the medical team to deliver the global medico-marketing strategy in Vietnam and instill the company value thru their daily activities.
  • Talent identification and development plan for individuals in Medicine team. Manage the talent pool within medicine for in and out of the department

Medical Chapter Lead (Country Medical Director)

Hoffmann La Roche Pharma Vietnam
10.2012 - 07.2023
  • Managed Medical Chapter effectively, collaborating closely with cross-functional team to focus on patient centricity, understand the patient journey and identify the need of healthcare community to foster the collaboration with stakeholders to address the umet medical need.
  • Led the Medical Team (including Clinical Operation function) to identify the early pipeline met, participated into global clinical studies, build cross-functions pre-launch readiness and successful execution number of launches in Vietnam market.
  • Established ans represented strong connection with KOLs, professional Associations and scientific community in Vietnam in order to build Roche's reputation in the Oncology and other communities in Vietnam.
  • Coached and developed medical team members who strongly contribute and make further impact to patient lives in Vietnam.
  • Contributed to number of Medical and cross-functional regional/global projects.

Head of Medical Affairs

Janssen Cilag- A Johnson and Johnson Company in VN
09.2009 - 09.2012

· Lead and hold the accountability for the execution of Medical Affairs Plans to support Product Brand objectives.

· Successful to establish Clinical Operation Unit in Vietnam to support Regional Clinical Operation activity including sites and investigators identifications and follow up with Authorities.

· Maintain scientific network with key thought leaders to develop strategic Partnerships

· Provide Medical Affairs Expert through medical input for important commercial meetings, regulatory strategy and company crisis management.


Project Director

New Lifes Vietnam
05.2008 - 08.2009
  • Developed and oversaw Hospital and Clinic Development project operations and managed multi-functional issues through resolution.

Head of Medical and Regulatory Affairs

Bayer Pharmaceuticals Vietnam
02.2004 - 04.2008
  • Manage and be responsible for regulatory submissions and compliance issues, including drug registration, drug reimbursement as well as other related licenses.
  • Manage key stakeholder relationships to promote a sensible regulatory environment in support of business objectives and priorities.
  • Medical Approval and Governance management. Provide medical related issues on strategic concepts in collaboration with marketing team.
  • Planning, conducting, monitoring and managing all clinical related studies in Vietnam

Regulatory Affairs Manager

Otsuka OPV Vietnam
09.2003 - 02.2004

· Manage and be responsible for regulatory submissions and compliance issues, including drug registration, drug reimbursement as well as other related licenses.

· Manage key stakeholder relationships to promote a sensible regulatory environment in support of business objectives and priorities.

Regulatory Affairs Head

Mega Products Vietnam
09.1998 - 08.2003

· Manage and be responsible for regulatory submissions and compliance issues, including drug registration, drug reimbursement as well as other related licenses.

· Manage key stakeholder relationships to promote a sensible regulatory environment in support of business objectives and priorities.

Project Executive

B.Braun Vietnam
10.1993 - 08.1998
  • Managed day-to-day operations of assigned projects, ensuring adherence to budgets, schedules, scopes, quality standards, policies, procedures.
  • Coordinated meetings with clients, vendors, and internal teams to facilitate smooth project progressions.


Education

MBA -

Asian Institute of Technology
Thailand
04.2001 -

Bachelor of Arts - International Trading

National Economic University
Hanoi, Vietnam
04.2001 -

M.D. - General Practitional

Hanoi Medical University
Hanoi
04.2001 -

Skills

Coaching and Mentoring

Accomplishments

Oncology at Roche

1.Successfully listed Vietnam into Clinical Study Map for Roche/Gennetech with the 1st ever phase 3 study in 2013 (Herceptin SC and Mabthera SC). Total 9 studies conducted in Vietnam within 10 years.

- Established procedure for HER2 testing, EGFR and ALK testing to support patient access and reimbursement.

- Launched successfully number of Oncology products: Mabthera SC in NHL, Herceptin SC, Kadcylar, Perjeta in BC, Tecentriq and Alecensa in LC.

- Early access for Polivy in relapse NHL

- Public Awareness on BC screening: We Care For Her/Joining Hand for Her (a foundation to enlisting BC screening package for reimbursement)

Specialty at Boehringer Ingelheim

- Attracting number of early phases clinical studies conducted in Vietnam: CatC in Bronchitis, EASi in HF, Spesolimab in HS and GPP

- Driving to obtain early access approval for Spevigo in GPP patients in Vietnam.

Work Preference

Work Type

Full Time

Work Location

On-Site

Important To Me

Company CultureCareer advancementPersonal development programsHealthcare benefits

Work Availability

monday
tuesday
wednesday
thursday
friday
saturday
sunday
morning
afternoon
evening
swipe to browse

Languages

English
Bilingual or Proficient (C2)

Interests

Gardening

Travelling

Photograph

Timeline

Head of Medicine

Boehringer Ingelheim HP
07.2023 - Current

Medical Chapter Lead (Country Medical Director)

Hoffmann La Roche Pharma Vietnam
10.2012 - 07.2023

Head of Medical Affairs

Janssen Cilag- A Johnson and Johnson Company in VN
09.2009 - 09.2012

Project Director

New Lifes Vietnam
05.2008 - 08.2009

Head of Medical and Regulatory Affairs

Bayer Pharmaceuticals Vietnam
02.2004 - 04.2008

Regulatory Affairs Manager

Otsuka OPV Vietnam
09.2003 - 02.2004

MBA -

Asian Institute of Technology
04.2001 -

Bachelor of Arts - International Trading

National Economic University
04.2001 -

M.D. - General Practitional

Hanoi Medical University
04.2001 -

Regulatory Affairs Head

Mega Products Vietnam
09.1998 - 08.2003

Project Executive

B.Braun Vietnam
10.1993 - 08.1998
Thu Van TrinhDr.